I was trained as a dermatologist in China, then earned a PhD degree in Investigative Dermatology from the Peking Union Medical College. I finished 3 years of postdoctoral fellowship training in skin cancers, especially in cutaneous T-cell lymphoma (CTCL) with Dr. Madeleine Duvic at the MD Anderson Cancer Center. Over the past years, I have conducted and completed multiple university-, private foundation-, industry-, and NIH-funded CTCL research projects as the PI, co-PI, or co-investigator. My research interests include tumor immune escape, immunotherapy, genomic changes and their therapeutic implications in CTCL. Our lab is among the first group of labs to have completed multiplatform genomic analysis in Sézary syndrome patients (Nature Genetics 47:1426-34, 2015). We are the only group using dermal fibroblasts cultured from the same patient as self-negative control for whole exome sequencing, which allowed us to identify unique driver mutations for CTCL. My career goal is continually learning and equipping myself with knowledge and science skills to find better ways to treat skin disease and skin cancer and improve human health and wellbeing.